Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 25, 2022	Dec. 26, 2021
Operating activities
Net income before attribution to noncontrolling interests	$ 82,799	$ 69,349	$ 124,955
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (benefit) for allowance for credit losses on accounts and notes receivable	5,393	20,539	(852)
Depreciation and amortization	64,090	52,032	48,816
Refranchising and impairment loss	0	12,065	0
Deferred income taxes	(5,991)	2,798	3,753
Stock-based compensation expense	17,924	18,388	16,919
Other	66	1,056	581
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(8,049)	(29,167)	4,023
Income tax receivable	6,212	586	(8,113)
Inventories	5,441	(7,496)	(4,708)
Prepaid expenses and other current assets	817	5,587	2,866
Other assets and liabilities	(11,803)	(13,458)	(20,077)
Accounts payable	23,371	(8,350)	(9,278)
Income and other taxes payable	9,087	(10,710)	9,733
Accrued expenses and other current liabilities	7,402	4,846	15,875
Deferred revenue	(3,704)	(257)	182
Net cash provided by operating activities	193,055	117,808	184,675
Investing activities
Purchases of property and equipment	(76,620)	(78,391)	(68,559)
Notes issued	(4,338)	(9,296)	(16,132)
Repayments of notes issued	4,655	13,045	18,555
Acquisitions, net of cash acquired	(5,613)	(1,219)	(699)
Proceeds from refranchising, net of cash transferred	0	13,588	0
Proceeds from the sale of property and equipment	3,457	0	0
Other	3,336	(520)	3,323
Net cash used in investing activities	(75,123)	(62,793)	(63,512)
Financing activities
Proceeds from issuance of senior notes	0	0	400,000
Net proceeds of revolving credit facilities	159,000	115,000	80,000
Debt issuance costs	0	0	(9,179)
Proceeds from exercise of stock options	2,252	4,036	11,969
Repurchase of Series B Convertible Preferred Stock	0	0	(188,647)
Acquisition of Company common stock	(210,348)	(125,000)	(72,499)
Dividends paid to common stockholders	(58,451)	(54,767)	(40,356)
Dividends paid to preferred stockholders	0	0	(6,394)
Tax payments for equity award issuances	(6,416)	(9,546)	(5,847)
Distributions to noncontrolling interests	(1,320)	(1,211)	(5,942)
Repayments of term loan	0	0	(340,000)
Principal payments on finance leases	(8,821)	(5,416)	(4,566)
Other	28	664	935
Net cash used in financing activities	(124,076)	(76,240)	(180,526)
Effect of exchange rate changes on cash and cash equivalents	(642)	(2,012)	(231)
Change in cash and cash equivalents	(6,786)	(23,237)	(59,594)
Cash and cash equivalents at beginning of period	47,373	70,610	130,204
Cash and cash equivalents at end of period	$ 40,587	$ 47,373	$ 70,610